首页> 外文期刊>American journal of medical genetics, Part A >Biallelic Mutations in Huntington Disease: A New Case with Just One Affected Parent, Review of the Literature and Terminology
【24h】

Biallelic Mutations in Huntington Disease: A New Case with Just One Affected Parent, Review of the Literature and Terminology

机译:亨廷顿病双等位基因突变:只有一名患病父母的新病例,文献和术语复习

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with biallelic mutations for Huntington disease (HD) are rare. We present a 46-year-old female with two expanded Huntingtin (HTT) alleles with just one known affected parent. This is the first reported patient with molecular studies performed to exclude HTT uniparental disomy (UPD). The proband had biparental inheritance of HTT alleles (42/44 CAG repeats). Given the negative UPD results, the proband's unaffected mother either had a reduced penetrance allele that expanded into the full mutation range during transmission to our patient or an unknown full HTT mutation and died before symptom onset, unlikely given no family history of HD and asymptomatic at age 59. We made the novel observation in our literature review that most patients with biallelic HD did not have two full HTT mutations. Most had one HTT allele that was in the intermediate or reduced penetrance ranges or 40 CAG repeats, the lowest limit of the full mutation range. Although the number of patients is small, when an allele in these size ranges was present, generally the age of HD onset was in the 50s. If the second HTT allele had >45 repeats, then onset was typically 20s-30s. While similar ages of onset have been reported for patients with one or two HTT mutations, patients with biallelic mutations may have later onset if an expanded HTT allele has 40 CAG repeats. Finally, we propose that biallelic mutations or compound heterozygosity are more accurate descriptive terms than homozygosity when there are two non-identical expanded HTT alleles. (c) 2015 Wiley Periodicals, Inc.
机译:患有亨廷顿病(HD)的双等位基因突变的患者很少。我们介绍了一个46岁的女性,有两个扩展的Huntingtin(HTT)等位基因,只有一个已知的受影响父母。这是首次报道的分子研究排除了HTT单亲二体性(UPD)患者。先证者具有HTT等位基因的双亲遗传(42/44 CAG重复)。鉴于UPD结果阴性,先证者的未受影响母亲的外显率等位基因减少,或者在传播给我们的患者时扩展到了完整突变范围,或者未知的完整HTT突变,并在症状发作之前死亡,考虑到没有HD家族史且无症状,这不太可能年龄59岁。我们在文献综述中做出了新颖的观察,即大多数双等位HD患者没有两个完整的HTT突变。大多数人有一个HTT等位基因,处于中等或降低的外显率范围或40个CAG重复,是整个突变范围的最低限度。尽管患者人数很少,但当存在这些大小范围的等位基因时,HD发作的年龄通常在50年代。如果第二个HTT等位基因具有> 45个重复,则发病通常为20s-30s。据报道,具有一或两个HTT突变的患者的发病年龄相似,但如果扩展的HTT等位基因具有40个CAG重复序列,则具有双等位基因突变的患者可能会晚些发作。最后,我们提出当存在两个不同的扩展HTT等位基因时,双等位基因突变或复合杂合性比纯合性更准确的描述性术语。 (c)2015年威利期刊有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号